<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2013-2-51-59</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-5552</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ ПОЛИМОРФИЗМА ГЕНОВ ЛИПИДТРАНСПОРТНОЙ СИСТЕМЫ У БОЛЬНЫХ НЕСТАБИЛЬНОЙ СТЕНОКАРДИЕЙ С ОТЯГОЩЕННЫМ СЕМЕЙНЫМ АНАМНЕЗОМ</article-title><trans-title-group xml:lang="en"><trans-title>CLINICAL VALUE DISTRIBUTION OF POLYMORPHISM OF THE LIPIDTRANSPORT SYSTEMS GENES IN PATIENTS WITH UNSTABLE ANGINA AND CORONARY HEART DISEASE IN FAMILY HISTORY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бекметова</surname><given-names>Феруза Матсапаевна</given-names></name><name name-style="western" xml:lang="en"><surname>Bekmetova</surname><given-names>F. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кан</surname><given-names>Лиля Эдиковна</given-names></name><name name-style="western" xml:lang="en"><surname>Kahn</surname><given-names>L. E.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хашимов</surname><given-names>Шавкат Уразалиевич</given-names></name><name name-style="western" xml:lang="en"><surname>Khashimov</surname><given-names>Sh. U.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тригулова</surname><given-names>Раиса Хусаиновна</given-names></name><name name-style="western" xml:lang="en"><surname>Trigulova</surname><given-names>R. Kh.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шек</surname><given-names>Александр Борисович</given-names></name><name name-style="western" xml:lang="en"><surname>Shek</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">cardiocenter@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курбанов</surname><given-names>Равшанбек Давлатович</given-names></name><name name-style="western" xml:lang="en"><surname>Kurbanov</surname><given-names>R. D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Республиканский специализированный центр кардиологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republican Specialized Center of Cardiology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2013</year></pub-date><volume>0</volume><issue>2</issue><fpage>51</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бекметова Ф.М., Кан Л.Э., Хашимов Ш.У., Тригулова Р.Х., Шек А.Б., Курбанов Р.Д., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Бекметова Ф.М., Кан Л.Э., Хашимов Ш.У., Тригулова Р.Х., Шек А.Б., Курбанов Р.Д.</copyright-holder><copyright-holder xml:lang="en">Bekmetova F.M., Kahn L.E., Khashimov S.U., Trigulova R.K., Shek A.B., Kurbanov R.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/5552">https://www.heartj.asia/jour/article/view/5552</self-uri><abstract><p>Цель. Изучить распределение полиморфизма генов аполипопротеинов А1, В и Е липидтранспортной системы у больных нестабильной стенокардией (НС) узбекской национальности с семейным анамнезом ИБС и их возможное влияние на клиническое течение и исходы заболевания. Материал и методы. Обследовано 125 больных узбекской национальности с НС, из которых 63 (I группа) имели отягощенный семейный анамнез, а 62 (II группа) не имели его. Группу контроля составили 58 здоровых лиц. G-A полиморфизм гена аполипопротеина A1 (АпоА1), -516C/T полиморфизм гена аполипопротеина B (АпоВ), ε2/є3/ є4 полиморфизм гена аполипопротеина E (АпоЕ) определяли с использованием набора реагентов Diatom TM DNA Prep 200 (производство ООО «Лаборатория ИзоГен»). Результаты. При изучении распределения «повреждающих» аллелей изучаемых генов среди больных НС в сравнении со здоровыми выявлена большая распространённость носительства аллели А АпоА1 ЮР 3,63, 95% ДИ 1,63-8,04, P=0,002). При сравнительном анализе II группы с группой контроля распределение «повреждающих» аллелей достоверно не различалось, тогда как в I группе отмечалось большее накопление аллелей «А» G-А полиморфизма гена АпоА1 ЮР 5,99, 95% ДИ 2,52-14,24,P=0,001) и аллели «є4» гена АпоЕ ЮР 2,91, 95%, ДИ 1,12-7,62 P=0,044). При этом не было выявлено различий в частоте носительства «Т» аллели -516C/T полиморфизма гена АпоВ. При годичном наблюдении отмечалась более высокая частота хирургических реваскуляризаций в группе больных с носительством «повреждающих» аллелей ЮР 3,43, 95%, ДИ 1,269,31, P=0,02). Заключение. Наличие семейного анамнеза ИБС среди узбеков с нестабильной стенокардией ассоциируется с накоплением аллелей: «А» (М1-) G-А полиморфизма гена АпоА1 и «є4» гена АпоЕ. При этом среди носителей «повреждающих» аллелей отмечена более высокая частота хирургических реваскуляризаций в течение года.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study influence of coronary heart disease (CHD) in family history on distribution of polymorphism apolipoprotein A1, В and E genes of the lipidtransport systems and major adverse cardiac events (MACE) in patients of Uzbek nationality with unstable angina (UA). Material and methods. There were examined 125 patients of Uzbek nationality with UA. I group (n=63) consisted of patients with burdened family history and II group (n=62) without family history. The control group consisted of 58 healthy persons. The G-A polymorphism of apolipoprotein A1 (APO A1) gene, -516C/T polymorphism of apolipoprotein В (APO B) gene and є2/є3/є4 polymorphism of apolipoprotein E (APO E) gene was determined using reagents Diatom TM DNA Prep 200 (production of LLC « IsoGen Laboratory») Results. In studying the distribution of «damaging» alleles of studied genes among the patients with UA in comparison with healthy persons, has been found a more prevalence of A allele carriers of the APO А1 (HR 3,63, 95% CI 1,638,04, P=0,002). The distribution of «damaging» alleles in comparative analysis of the II group with healthy persons did not differ significantly, whereas in I group had significantly greater accumulation of alleles: «А» G-А polymorphism of APO А1 gene (HR 5,99, 95% CI 2,52-14,24,P=0,001), «є4» polymorphism of APO E gene (HR 2,91, 95%, CI 1,12-7,62 P=0,044). At the same time there was no difference in the frequency of carriage «T» allele of -516C / T polymorphism of APO B gene. In patients with carriage of «damaging» alleles it was observed high frequency surgical revascularisations (HR 3,43, 95 %, CI 1,26-9,31, P=0,02) within one year. Conclusion. Presence of CHD in family history among patients of Uzbek nationality with UA is associated with the accumulation of «damaging» alleles: «А» (M1-) G-A polymorphism of APO A1, «є4» of APO E gene, and «D» I/D polymorphism of ACE gene. In patients with carriage of «damaging» alleles it was observed high frequency surgical revascularisations within one year.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>полиморфизм генов липидтранспортной системы</kwd><kwd>нестабильная стенокардия</kwd><kwd>отягощенный семейный анамнез</kwd><kwd>polymorphism of the lipidtransport systems genes</kwd><kwd>unstable angina</kwd><kwd>family history of coronary heart disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Van't Hooft, F. M., S. Jormsjo, B. Lundahl, P. Tornvall, P Eriksson, and A. Hamsten. A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein. J. Lipid Res 1999; 40:1686-1694.</mixed-citation><mixed-citation xml:lang="en">Van't Hooft, F. M., S. Jormsjo, B. Lundahl, P. Tornvall, P Eriksson, and A. Hamsten. A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein. J. Lipid Res 1999; 40:1686-1694.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Yangchun, Hu Dayi, Yang Xinchun et al. Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease. Chinese Medical Journal 2003; 116:5:665-668.</mixed-citation><mixed-citation xml:lang="en">Zou Yangchun, Hu Dayi, Yang Xinchun et al. Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease. Chinese Medical Journal 2003; 116:5:665-668.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gerdes L.U., Jeune B., Ranberg K.A. et al. Estimation of apolipoprotein Egenotype specific relative mortality from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a «frailty gene», not a «longevity gene» Genetic Epidemiol 2000;19:202-210.</mixed-citation><mixed-citation xml:lang="en">Gerdes L.U., Jeune B., Ranberg K.A. et al. Estimation of apolipoprotein Egenotype specific relative mortality from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a «frailty gene», not a «longevity gene» Genetic Epidemiol 2000;19:202-210.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Jeenah M., Kessling A, Miller N., Humphries SE. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990;7:233-241.</mixed-citation><mixed-citation xml:lang="en">Jeenah M., Kessling A, Miller N., Humphries SE. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990;7:233-241.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pagani F., Sidoli A., Giudici G.A. et al. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 1990;31:1371-1377.</mixed-citation><mixed-citation xml:lang="en">Pagani F., Sidoli A., Giudici G.A. et al. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 1990;31:1371-1377.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Civeira F., Pocovi M., Cenarro A., et al. Adenine for guanine substitution -78 base pairs to the apolipoprotein (APO) A-I gene: relation with high-density lipoprotein cholesterol and apoA-I concentrations. Clin Genet 1993;44:307-312.</mixed-citation><mixed-citation xml:lang="en">Civeira F., Pocovi M., Cenarro A., et al. Adenine for guanine substitution -78 base pairs to the apolipoprotein (APO) A-I gene: relation with high-density lipoprotein cholesterol and apoA-I concentrations. Clin Genet 1993;44:307-312.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X.L., Liu S.X., McCredie R.M., Wilcken DEL. Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 1996;98:372-377.</mixed-citation><mixed-citation xml:lang="en">Wang X.L., Liu S.X., McCredie R.M., Wilcken DEL. Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 1996;98:372-377.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Matsunaga A., Sasaki J., Mori T. et al. Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls. Nutr Metab Cardiovasc Dis 1995;5:269-275.</mixed-citation><mixed-citation xml:lang="en">Matsunaga A., Sasaki J., Mori T. et al. Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls. Nutr Metab Cardiovasc Dis 1995;5:269-275.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ali I Albahrani, Jannete Usher J., Mohammed Alkindi et al.ApolipoproteinA1-75 G/A (M1-) polymorphism and Lipoprotein(a) Anti- versus Pro-Atherogenic properties. Lipids in Health and Disease 2007;6:19.</mixed-citation><mixed-citation xml:lang="en">Ali I Albahrani, Jannete Usher J., Mohammed Alkindi et al.ApolipoproteinA1-75 G/A (M1-) polymorphism and Lipoprotein(a) Anti- versus Pro-Atherogenic properties. Lipids in Health and Disease 2007;6:19.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Heng C.K., Low P.S., Saha N.: Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein (a) levels in Asian Indian neonates from Singapore. Pediatr Res 2001;49:514-518.</mixed-citation><mixed-citation xml:lang="en">Heng C.K., Low P.S., Saha N.: Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein (a) levels in Asian Indian neonates from Singapore. Pediatr Res 2001;49:514-518.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Requero J.R., Cubero G.I., Batalla A. et al. Apolipoprotein AI gene polymorphisms and risk of early Coronary disease Cardiology 1998; 90:231-235.</mixed-citation><mixed-citation xml:lang="en">Requero J.R., Cubero G.I., Batalla A. et al. Apolipoprotein AI gene polymorphisms and risk of early Coronary disease Cardiology 1998; 90:231-235.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Song Y., Stampfer M.J., Liu S. Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease Ann. Int. Med. 2004;141:2:137-147.</mixed-citation><mixed-citation xml:lang="en">Song Y., Stampfer M.J., Liu S. Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease Ann. Int. Med. 2004;141:2:137-147.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gerdes L.U., Gerdes C., Kervinen K. et al. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study Circulation 2000;101:1366-1371.</mixed-citation><mixed-citation xml:lang="en">Gerdes L.U., Gerdes C., Kervinen K. et al. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study Circulation 2000;101:1366-1371.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chiodini B.D., Franzosi M. G., Barlera S., et al. Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study.</mixed-citation><mixed-citation xml:lang="en">Chiodini B.D., Franzosi M. G., Barlera S., et al. Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione study.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
